Literature DB >> 22351604

PBPK as a tool in regulatory review.

Shiew-Mei Huang1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22351604     DOI： 10.1002/bdd.1777

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN： 0142-2782            Impact factor:   1.627


× No keyword cloud information.
  11 in total

1.  Herb-drug interactions: challenges and opportunities for improved predictions.

Authors:  Scott J Brantley; Aneesh A Argikar; Yvonne S Lin; Swati Nagar; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

2.  Case studies for practical food effect assessments across BCS/BDDCS class compounds using in silico, in vitro, and preclinical in vivo data.

Authors:  Tycho Heimbach; Binfeng Xia; Tsu-han Lin; Handan He
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

3.  Predicting nonlinear pharmacokinetics of omeprazole enantiomers and racemic drug using physiologically based pharmacokinetic modeling and simulation: application to predict drug/genetic interactions.

Authors:  Fang Wu; Lu Gaohua; Ping Zhao; Masoud Jamei; Shiew-Mei Huang; Edward D Bashaw; Sue-Chih Lee
Journal:  Pharm Res       Date:  2014-03-04       Impact factor: 4.200

Review 4.  Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group.

Authors:  K L R Brouwer; L M Aleksunes; B Brandys; G P Giacoia; G Knipp; V Lukacova; B Meibohm; S K Nigam; M Rieder; S N de Wildt
Journal:  Clin Pharmacol Ther       Date:  2015-09       Impact factor: 6.875

5.  Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling.

Authors:  Manoj S Chiney; Juki Ng; John P Gibbs; Mohamad Shebley
Journal:  Clin Pharmacokinet       Date:  2020-05       Impact factor: 6.447

6.  Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for valproic acid and divalproex.

Authors:  Todd M Conner; Vahagn C Nikolian; Patrick E Georgoff; Manjunath P Pai; Hasan B Alam; Duxin Sun; Ronald C Reed; Tao Zhang
Journal:  Eur J Pharm Sci       Date:  2017-10-10       Impact factor: 4.384

7.  Novel orally swallowable IntelliCap(®) device to quantify regional drug absorption in human GI tract using diltiazem as model drug.

Authors:  Dieter Becker; Jin Zhang; Tycho Heimbach; Robert C Penland; Christoph Wanke; Jeff Shimizu; Kenneth Kulmatycki
Journal:  AAPS PharmSciTech       Date:  2014-07-15       Impact factor: 3.246

Review 8.  PBPK modeling and simulation in drug research and development.

Authors:  Xiaomei Zhuang; Chuang Lu
Journal:  Acta Pharm Sin B       Date:  2016-06-23       Impact factor: 11.413

9.  Integrating In Vitro, Modeling, and In Vivo Approaches to Investigate Warfarin Bioequivalence.

Authors:  X Zhang; H Wen; J Fan; B Vince; T Li; W Gao; M Kinjo; J Brown; W Sun; W Jiang; R Lionberger
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-07-13

10.  Application of physiologically based pharmacokinetic modeling in predicting drug-drug interactions for sarpogrelate hydrochloride in humans.

Authors:  Jee Sun Min; Doyun Kim; Jung Bae Park; Hyunjin Heo; Soo Hyeon Bae; Jae Hong Seo; Euichaul Oh; Soo Kyung Bae
Journal:  Drug Des Devel Ther       Date:  2016-09-14       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.